ID JOS-SHK.0000000000000817
著者:名前 著者:別形式 Murata, Isamu / Miyake, Yumi / Takahashi, Naomi / Suzuki, Ryuta / Fujiwara, Takayuki / Sato, Yuji / Inoue, Yutaka / Kobayashi, Jun / Kanamoto, Ikuo
著者:カナ 著者:所属 城西大学薬学部医薬品安全性学研究室 / 城西大学薬学部医薬品安全性学研究室 / 城西大学薬学部医薬品安全性学研究室 / 城西大学薬学部医薬品安全性学研究室 / 城西大学薬学部医薬品安全性学研究室 / 城西大学薬学部医薬品安全性学研究室 / 城西大学薬学部医薬品安全性学研究室 / 城西大学薬学部医療栄養学科病態解析学 / 城西大学薬学部医薬品安全性学研究室
著者:所属(別形式) Josai University, Faculty of Pharmaceutical Science, Laboratory of Drug Safety Management / Josai University, Faculty of Pharmaceutical Science, Laboratory of Drug Safety Management / Josai University, Faculty of Pharmaceutical Science, Laboratory of Drug Safety Management / Josai University, Faculty of Pharmaceutical Science, Laboratory of Drug Safety Management / Josai University, Faculty of Pharmaceutical Science, Laboratory of Drug Safety Management / Josai University, Faculty of Pharmaceutical Science, Laboratory of Drug Safety Management / Josai University, Faculty of Pharmaceutical Science, Laboratory of Drug Safety Management / Josai University, Faculty of Pharmaceutical Science, Laboratory of Drug Safety Management / Josai University, Faculty of Pharmaceutical Science, Department of Clinical Dietetics and Human Nutrition, Division of Pathophysiology
著者版フラグ author
出版者 Lippincott Williams & Wilkins
冊子ISSN 10732322
電子ISSN 15400514
掲載誌名 巻 48
号 1
刊行年月 2017-07
開始ページ 112
終了ページ 118
コンテンツ作成日 2016-09-28
コンテンツ修正日 2016-11-30
コンテンツ登録日 2018-07-26
識別番号:DOI info:doi/10.1097/SHK.0000000000000817
識別番号:DOI(リンク) PubMed番号 27941593
抄録 Objective: Crush syndrome (CS) is a serious medical condition characterized by muscle cell damage resulting from pressure. CS has a high mortality, even when patients receive fluid therapy. We examined whether administration of NaNO2-containing fluid can improve survival in a rat model of CS.Design: The CS model was generated by subjecting anesthetized rats to bilateral hind limb compression with a rubber tourniquet for 5 h. Rats were then randomly divided into six groups: sham; CS with no treatment; CS with normal saline treatment; CS with normal saline + 25 mEq/L bicarbonate treatment; and CS with normal saline + 200 or 500 μmol/kg NaNO2.Measurements and Main Results: Blood and tissue samples were collected for histological and biochemical analyses at predetermined time points before and after reperfusion. Ischemic compression of rat hind limbs reduced nitrite content in the crushed muscle, and subsequent reperfusion resulted in reactive oxygen species-induced circulatory dysfunction and systemic inflammation. Rats treated with 200 μmol/kg NaNO2 showed increased nitric oxide (NO) levels, blood circulation, and neoangiogenesis, decreased generation of reactive oxygen species, and suppression of the inflammatory response, leading to complete recovery.Conclusions: Treatment with 200 μmol/kg NaNO2 prevents muscle damage induced by ischemia reperfusion via the protective effects of NO and suppression of systemic inflammation, thereby increasing survival rates in CS.
キーワード 言語 eng
資源タイプ text
ジャンル フォーマット application/pdf
権利 Copyright © 2016 by the Shock Society
このアイテムを表示する:本文(pdf) ( 1.5MB) ダウンロード回数:
回
このアイテムを表示する:URI